We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tissue Regenix Group Plc | LSE:TRX | London | Ordinary Share | GB00BNTXR104 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 0.82% | 61.50 | 61.00 | 62.00 | 61.50 | 61.50 | 61.50 | 18,448 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 29.49M | -302k | -0.0043 | -143.02 | 43.4M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/3/2015 18:49 | Cheers Ray. Welcome temmujin. 500,000 late trade showing, not sure when from. The other states should follow with the Medicare approval in due course. I hope we'll be getting ongoing reports from the US of progress with the Stage IV Clinical Trial. | bamboo2 | |
09/3/2015 17:49 | Yes bamboo, saw the rns. Quite a wait? I'm a patient man.😉 | rayrac | |
09/3/2015 16:57 | 09 March 2015 Tissue Regenix Group plc Notice of Preliminary Results YORK, 9(th) March 2015 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix"), the regenerative medical devices company, announces that it will publish its unaudited preliminary results for the year ended 31 January 2015, on Monday 11(th) May 2015. | bamboo2 | |
06/3/2015 12:24 | Had another little top up today. | luminoso | |
06/3/2015 10:09 | i'm in !..looks way under valued | temmujin | |
06/3/2015 08:28 | Brill news ! Nice of them to release the teaser yesterday then the biggie today. | igbertsponk | |
06/3/2015 08:19 | Look what happened at BTG! That's based to a great extent on varicose vein treatment. TRX have, in my opinion, a much bigger market? | rayrac | |
06/3/2015 08:17 | Great news, sounds like more to come as well.... | bobsgonnamakemerich | |
06/3/2015 08:08 | It's not on everyone's radar just yet. Give it time!! | rayrac | |
06/3/2015 08:06 | Cheers Ray, quite a few early buys, we haven't seen this kind of excitement for some time! | bamboo2 | |
06/3/2015 07:58 | I agree, I agree I agree 😜 | rayrac | |
06/3/2015 07:54 | I think this kind of RNS could attract the attention of the KCI's of this world. | bamboo2 | |
06/3/2015 07:52 | Our patience is about to be rewarded! Just cresting the hill, the view is about to improve... | rayrac | |
05/3/2015 12:54 | Hmmm - one swallow does not make a summer. One operation is not a gurantee of success. This ist the sort of RNS that a pharma co would send out. I hope our standards are not that low. Lets see one that says sales are booming and the goods are flying out of the factory. | swiss paul | |
05/3/2015 11:26 | Well, there is some newsflow ! Early days for this Orthopure XM trial but good news all the same. Good to see the product will be launched in the EU in 2016 and the demand that is there for it. Might explain the little flurry of activity in the share price yesterday ! | luminoso | |
04/3/2015 17:55 | Andrew, all good points. The chart showed a small head and shoulders that is now complete. Newsflow should get going again soon, with some interim info from the US clinical trial, and hopefully some further confirmation of the start of commercial activities. | bamboo2 | |
04/3/2015 17:37 | The price has once again got to very interesting levels. Being a small company the share price will fluctuate, but at its current level, it is temping to buy more. The product is excellent, barriers to entry extremely high, and the demand will never be less than very good. I am showing a substantial profit thus far, and buying more may make my portfolio a tad TRX-heavy, but it would likely be worth doing. | andrewbaker | |
04/3/2015 16:01 | Hmmm. Not entirely convinced that 284k was a sale. | luminoso | |
04/3/2015 15:32 | Some interesting price action these last few minutes. Sharp fall and mostly buys recorded. Was it just walked down to accomodate someone ? | luminoso | |
03/3/2015 08:27 | bamboo - a company needs independent NEDs to stand up for the rights of the independent shareholders like us. If they haven't got any, there's no NEDs to agree the correct price for a takeover if they're all doing what is good for their employer rather than the shareholders as a whole. The Company agree with me too "In accordance with the Company's strategy to evolve the composition of the Board, the search for an independent Non-Executive Director is well underway." | igbertsponk |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions